Associated Papers
Unplugging lateral fenestrations of NALCN reveals a hidden drug binding site within the pore region.
Schott K et al.
Proceedings of the National Academy of Sciences of the United States of America, 2024
Unplugging lateral fenestrations of NALCN reveals a hidden drug binding site within the pore module.
Schott K et al.
Biorxiv : the Preprint Server for Biology, 2024
Case Report: A de novo Variant in NALCN Associated With CLIFAHDD Syndrome in a Chinese Infant.
Liao Z et al.
Frontiers in Pediatrics, 2022
Structure of the human sodium leak channel NALCN in complex with FAM155A.
Xie J et al.
Nature Communications, 2020
33203861 (PubMed )
Supplement: 41467_2020_19667_MOESM1_ESM.pdf
Functional expression of CLIFAHDD and IHPRF pathogenic variants of the NALCN channel in neuronal cells reveals both gain- and loss-of-function properties.
Bouasse M et al.
Scientific Reports, 2019
NALCN channelopathies: Distinguishing gain-of-function and loss-of-function mutations.
Bend EG et al.
Neurology, 2016
A Gain-of-Function Mutation in NALCN in a Child with Intellectual Disability, Ataxia, and Arthrogryposis.
Aoyagi K et al.
Human Mutation, 2015
De novo mutations in NALCN cause a syndrome characterized by congenital contractures of the limbs and face, hypotonia, and developmental delay.
Chong JX et al.
American Journal of Human Genetics, 2015
Select a paper to view details